Skip to Content

Direxion Daily S&P Biotech Bull 3X Shares

LABU
$
Today’s Change
()

Snapshot
*

Inception Date
May 28, 2015
Expense Ratio
0.95%
Type
US Equities
Fund Owner
Direxion Shares
Volume (1m avg. daily)
$115,253,074
AUM
$860,283,405
Associated Index
S&P Biotechnology Select Industry Index
Inverse/Leveraged
Leveraged (3x)
Passive/Active
Passive
Fractionable on Composer
Yes
Prospectus

Top 10 Holdings

DREYFUS GOVT CASH MAN INS
5.43%
GOLDMAN FINL SQ TRSRY INST 506
3.48%
GOLDMAN SACHS FIN GOV 465 INSTITUT
1.66%
DREYFUS TRSRY SECURITIES CASH MGMT
0.94%
MRTX
Mirati Therapeutics Inc
0.35%
APLS
Apellis Pharmaceuticals Inc
0.32%
SGEN
Seagen Inc
0.32%
NBIX
Neurocrine Biosciences, Inc.
0.32%
IONS
Ionis Pharmaceuticals Inc
0.31%
AMGN
AMGEN Inc.
0.31%

What is LABU?

The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.

1M
3M
6M
YTD
1Y
3Y
Max

LABU
Performance Measures**

for the time period May 28, 2015 to Dec 4, 2025

Returns

1M Trailing Return: 44.0%

The percent change in the value over the most recent 1-month period.

3M Trailing Return: 114.5%

The percent change in the value over the most recent 3-month period.

Measures of Risk or Volatility

Max Drawdown: -99.2%

The greatest percent loss from peak to trough in value over the time period.

Standard Deviation: 98.9%

The typical amount that daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

Measures of Risk-Adjusted Performance

Sharpe Ratio: 0.22

The annualized arithmetic mean of the daily returns divided by the annualized standard deviation of the daily returns for the selected time period.

Calmar Ratio: -0.24

The annualized return divided by the max drawdown for the selected time period.

ETFs related toLABU

ETFs correlated to LABU include XBI, GNOM, IBB

LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
XBI
SPDR Series Trust - SPDR Biotech ETF
GNOM
Global X Funds - Global X Genomics & Biotechnology ETF
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund
ARKG
ARK Investment Management LLC - ARK Genomic Revolution ETF
IWC
BlackRock Institutional Trust Company N.A. - iShares Micro-Cap ETF
XPH
SPDR Series Trust - SPDR Pharmaceuticals ETF
IWO
BlackRock Institutional Trust Company N.A. - iShares Russell 2000 Growth ETF
VTWG
Vanguard Group, Inc. - Vanguard Russell 2000 Growth Index ETF
VBK
Vanguard Group, Inc. - Vanguard Small Cap Growth ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

Trading Strategies
Related toLABU

Wooden ARKK Machine 2.2a

Category

Tactical, mean-reversion, momentum filter, leveraged/inverse ETFs, single-position, daily, risk-managed, multi-asset

OOS Cumulative Return

584.43%

Simons KMLM switcher (single pops)| BT 4/13/22 = A.R. 466% / D.D. 22% V2

Category

Tactical, leveraged ETFs, volatility, mean reversion, trend following, regime switching, risk-on/risk-off

OOS Cumulative Return

568.34%

Create your own algorithmic trading strategy with LABU using Composer

FAQ

LABU is a US Equities ETF. The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.

LABU tracks the S&P Biotechnology Select Industry Index.

No, LABU is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, LABU is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on LABU is -0.2219%. This is the percent change in the value of LABU over the most recent 1-month period. The 3-month return on LABU is -0.3848%. This is the percent change in the value of LABU over the most recent 3-month period.

The standard deviation of LABU for the past year is 0.8694%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to LABU include SSO, QID, and SPXL.

ETFs correlated to LABU include XBI, GNOM, and IBB.

ETFs that are inversely correlated to LABU include LABD, SRTY, and TWM.

Yes, LABU is a Leveraged (3x) ETF: This means that LABU will try to match the performance of S&P Biotechnology Select Industry Index, but with 3x the returns.

No, LABU is not an inverse ETF.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.